Sean Ellis - Jan 1, 2022 Form 3/A - Amendment Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
Stock symbol
ENTX
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
3/A - Amendment
Date filed
7/25/2022, 05:23 PM
Date Of Original Report
Jan 14, 2022
Next filing
Jul 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENTX Ordinary Shares, par value NIS 0.0000769 per share 7.2K Jan 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENTX Warrants (right to buy) Jan 1, 2022 Ordinary Shares, par value NIS 0.0000769 per share 3K $5.85 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3 amendment is being filed to correct the original Form 3 filed on January 14, 2022. The original Form 3 inadvertently omitted ordinary shares directly held by the Reporting Person.
F2 This Form 3 amendment is being filed to correct the original Form 3 filed on January 14, 2022. The original Form 3 inadvertently omitted warrants to purchase ordinary shares directly held by the Reporting Person.